Tonello, M., Baratti, D., Sammartino, P., Di Giorgio, A., Robella, M., Sassaroli, C., . . . Sommariva, A. (2022). Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Annals of Surgical Oncology, 29(6), 3405-3417. https://doi.org/10.1245/s10434-021-11045-3
Chicago-referens (17:e uppl.)Tonello, Marco, et al. "Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)." Annals of Surgical Oncology 29, no. 6 (2022): 3405-3417. https://doi.org/10.1245/s10434-021-11045-3.
MLA-referens (9:e uppl.)Tonello, Marco, et al. "Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)." Annals of Surgical Oncology, vol. 29, no. 6, 2022, pp. 3405-3417, https://doi.org/10.1245/s10434-021-11045-3.
